等待開盤
0.000
NaN.00%
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index fa...
2025-11-04 03:23
Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today that it has entered
2024-09-16 19:08